Stem Cell Sciences Signs Service Agreement With Pfizer to Provide Access to Proprietary Technologies and Methods
24-Nov-2008 -
Stem Cell Sciences plc has signed a Master Service Agreement of up to five years with Pfizer Limited, the UK operating unit of the global research-based pharmaceutical company Pfizer, Inc.. Under the terms of the agreement, SCS will provide research services, cell lines, media and reagents to ...
Bio-Medical Research
cell lines
Pfizer
+5